BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11228057)

  • 1. Dehydroepiandrosterone suppresses elevated hepatic glucose-6-phosphatase mRNA level in C57BL/KsJ-db/db mice: comparison with troglitazone.
    Aoki K; Kikuchi T; Mukasa K; Ito S; Nakajima A; Satoh S; Okamura A; Sekihara H
    Endocr J; 2000 Dec; 47(6):799-804. PubMed ID: 11228057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dehydroepiandrosterone suppresses the elevated hepatic glucose-6-phosphatase and fructose-1,6-bisphosphatase activities in C57BL/Ksj-db/db mice: comparison with troglitazone.
    Aoki K; Saito T; Satoh S; Mukasa K; Kaneshiro M; Kawasaki S; Okamura A; Sekihara H
    Diabetes; 1999 Aug; 48(8):1579-85. PubMed ID: 10426376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dehydroepiandrosterone decreases elevated hepatic glucose production in C57BL/KsJ-db/db mice.
    Aoki K; Taniguchi H; Ito Y; Satoh S; Nakamura S; Muramatsu K; Yamashita R; Ito S; Mori Y; Sekihara H
    Life Sci; 2004 May; 74(25):3075-84. PubMed ID: 15081573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of hepatic gluconeogenesis in long-term Troglitazone treated diabetic KK and C57BL/KsJ-db/db mice.
    Fujiwara T; Okuno A; Yoshioka S; Horikoshi H
    Metabolism; 1995 Apr; 44(4):486-90. PubMed ID: 7723671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphodiesterase 3B gene expression is enhanced in the liver but reduced in the adipose tissue of obese insulin resistant db/db mouse.
    Tang Y; Osawa H; Onuma H; Nishimiya T; Ochi M; Sugita A; Makino H
    Diabetes Res Clin Pract; 2001 Dec; 54(3):145-55. PubMed ID: 11689269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Troglitazone inhibits expression of the phosphoenolpyruvate carboxykinase gene by an insulin-independent mechanism.
    Davies GF; Khandelwal RL; Roesler WJ
    Biochim Biophys Acta; 1999 Aug; 1451(1):122-31. PubMed ID: 10446394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dehydroepiandrosterone on gluconeogenic enzymes and glucose uptake in human hepatoma cell line, HepG2.
    Yamashita R; Saito T; Satoh S; Aoki K; Kaburagi Y; Sekihara H
    Endocr J; 2005 Dec; 52(6):727-33. PubMed ID: 16410665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice.
    Fujiwara T; Wada M; Fukuda K; Fukami M; Yoshioka S; Yoshioka T; Horikoshi H
    Metabolism; 1991 Nov; 40(11):1213-8. PubMed ID: 1943750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of troglitazone, a new oral antidiabetic agent, on fructose-induced insulin resistance.
    Yagi N; Takasu N; Higa S; Ishikawa K; Murakami K; Mimura G
    Horm Metab Res; 1995 Oct; 27(10):439-41. PubMed ID: 8575720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel hypoglycemic agent YM440 normalizes hyperglycemia without changing body fat weight in diabetic db/db mice.
    Shimaya A; Kurosaki E; Nakano R; Hirayama R; Shibasaki M; Shikama H
    Metabolism; 2000 Mar; 49(3):411-7. PubMed ID: 10726922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.
    Memon RA; Tecott LH; Nonogaki K; Beigneux A; Moser AH; Grunfeld C; Feingold KR
    Endocrinology; 2000 Nov; 141(11):4021-31. PubMed ID: 11089532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial insulin-sensitizing and vascular effects of S15261 in the insulin-resistant JCR:LA-cp rat.
    Russell JC; Ravel D; Pégorier JP; Delrat P; Jochemsen R; O'Brien SF; Kelly SE; Davidge ST; Brindley DN
    J Pharmacol Exp Ther; 2000 Nov; 295(2):753-60. PubMed ID: 11046115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Troglitazone action is independent of adipose tissue.
    Burant CF; Sreenan S; Hirano K; Tai TA; Lohmiller J; Lukens J; Davidson NO; Ross S; Graves RA
    J Clin Invest; 1997 Dec; 100(11):2900-8. PubMed ID: 9389757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
    Okuno A; Tamemoto H; Tobe K; Ueki K; Mori Y; Iwamoto K; Umesono K; Akanuma Y; Fujiwara T; Horikoshi H; Yazaki Y; Kadowaki T
    J Clin Invest; 1998 Mar; 101(6):1354-61. PubMed ID: 9502777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL.
    Chen Z; Ishibashi S; Perrey S; Osuga Ji ; Gotoda T; Kitamine T; Tamura Y; Okazaki H; Yahagi N; Iizuka Y; Shionoiri F; Ohashi K; Harada K; Shimano H; Nagai R; Yamada N
    Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):372-7. PubMed ID: 11231916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of diabetes, hepatic injury, and colon cancer with dehydroepiandrosterone.
    Aoki K; Nakajima A; Mukasa K; Osawa E; Mori Y; Sekihara H
    J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):469-72. PubMed ID: 12943737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration in expression profiles of a series of diabetes-related genes in db/db mice following treatment with thiazolidinediones.
    Suzuki A; Yasuno T; Kojo H; Hirosumi J; Mutoh S; Notsu Y
    Jpn J Pharmacol; 2000 Oct; 84(2):113-23. PubMed ID: 11128033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-diabetic effects of ethanol extract from two variants of Artemisia princeps Pampanini in C57BL/KsJ-db/db mice.
    Jung UJ; Baek NI; Chung HG; Bang MH; Yoo JS; Jeong TS; Lee KT; Kang YJ; Lee MK; Kim HJ; Yeo JY; Choi MS
    Food Chem Toxicol; 2007 Oct; 45(10):2022-9. PubMed ID: 17574717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.
    Miles PD; Higo K; Romeo OM; Lee MK; Rafaat K; Olefsky JM
    Diabetes; 1998 Mar; 47(3):395-400. PubMed ID: 9519745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat.
    Lee MK; Miles PD; Khoursheed M; Gao KM; Moossa AR; Olefsky JM
    Diabetes; 1994 Dec; 43(12):1435-9. PubMed ID: 7958495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.